Cite
HARVARD Citation
Orlando, I. et al. (2017). Long‐term efficacy and safety of the interleukin‐1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma. Internal medicine journal. 47 (9), pp. 1086-1088. [Online].